Premium
AAP urges pediatricians to prescribe buprenorphine
Publication year - 2016
Publication title -
the brown university child and adolescent psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7567
pISSN - 1527-8395
DOI - 10.1002/cpu.30153
Subject(s) - buprenorphine , naltrexone , medicine , methadone , opioid use disorder , opioid , narcotic antagonists , (+) naloxone , family medicine , intensive care medicine , psychiatry , receptor
In “Medication‐Assisted Treatment of Adolescents With Opioid Use Disorders,” published online August 22, the American Academy of Pediatrics (AAP) urges its members to make buprenorphine available to patients with opioid use disorders. A leading cause of morbidity and mortality among youth in the United States, opioid use disorders have effective treatments, both medications (methadone, buprenorphine, and naltrexone) and counseling, but access to appropriate treatment is restricted, especially for adolescents. The AAP noted that resources are needed to communicate information about the effective treatments, as well as to develop new treatment especially for this age group.